Succeed in your healthcare transactions

Tech-enabled investment bank —  M&A and financing for Healthcare companies

Our services

100% Healthcare

Our entire commitment to healthcare innovation aims to improve its systems and make an impact

In-depth expertise

By fully embracing your project, we determine your market position in order to reach the most relevant investors and buyers

Enabled by Tech

Leveraging top-notch technologies, we enhance our transaction processes to deliver maximum value to our clients

Our services

Healthcare transaction advisory

We expertly manage and optimize healthcare transactions, leveraging our specialized network for your success

Financing Advisory

Dedicated to promising healthcare companies, startups, or scale-ups seeking to raise funds

Buy-side M&A Advisory

Corporate Finance As A Service (CFAaS) Dedicated to corporates of any size seeking to build and/or execute an external growth strategy

Sell-side M&A Advisory

Dedicated to entrepreneurs looking to sell their businesses or funds seeking to exit their investments

Our services

Tell us about your project

Based in Europe, operates globally

Dedicated to small  & mid cap market

Our Scope

Our expertise across the whole healthcare value chain

Discover our verticals

Equipments

Manufacturing tools • Consumables • Materials

Services

CRO • CDMOs • Distributors • HR services

Therapeutics

Biotech • Mature molecules

Digital Health

Digital therapies • Professional softwares • Pathways digitization • AI-based imagery

Medtech

Diagnostics • Bio-materials and implants • Medical devices

OUR TEAM

An operational team surrounded by industry experts

Grégoire Weber

Analyst

Jean-Hugues Masgnaux

Operating Advisor

Founder M&M conseil

David Halphen

Advisor

Site Head Nanobiotix

Maurice Sofeir

Senior Advisor

Ex CSO Sanofi

For each project, we gather experts tailored to your needs and manage the entire process with deep, specialized knowledge.

Meet our expert team

Optimization of transaction strategy supported by indutry insights

Exclusive access to key accounts

Operational excellence

Financing

August 2024

"Klutch Capital members are extremely professional with a large expertise in the different facets of the pharmaceutical business. They were very alert and reactive to our requests and got us introduced to relevant investors and corporations. Attentive, well organized, always in contact with their clients"

Jean Pierre Lehner - Founder Sirona Biosciences

Sell-side M&A

September 2024

"We would like to express our complete satisfaction with the outstanding support provided by the Klutch Capital team in preparing presentations for companies in the MEGA group, particularly Mega Biopharma and Blue Skincare. Their undeniable expertise and constant commitment were essential in effectively structuring our prospecting efforts for strategic partnerships and fundraising."

Didier Bensadoun - Mega Biopharma CEO

Sell-side M&A

September 2024

"Klutch Capital demonstrates great professional rigor and expertise in our transaction. Thanks to their support, we were able to establish a partnership with a major pharmaceutical group. Klutch Capital also ensures thorough follow-up between both parties"

Alexia Adda, Quitoxil CEO